Literature DB >> 33618667

Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.

Yang Li1, Zirong Liu1, Yamin Zhang2.   

Abstract

BACKGROUND: Despite the high number of researches on pancreatic adenocarcinoma (PAAD) over past decades, little progress had been made due to lack of effective treatment regimens. We aimed to investigate the expression level, mutation, and clinical significance of the Frizzled (FZD) family in PAAD so as to establish a sufficient scientific evidence for clinical decisions and risk management.
METHODS: PAAD samples were extracted from The Cancer Genome Atlas (TCGA). Oncomine, Gene expression profiling interactive analysis (GEPIA), human protein atlas (HPA), Kaplan-Meier Plotter, cBioPortal, LinkedOmics, DAVID database, and R software (× 64 3.6.2) were used to comprehensively analyze the roles of FZDs. p value below to 0.05 was considered as significant difference.
RESULTS: In total, 179 PAAD tissues and 171 paracancerous tissues were included. The expression levels of FZD1, 2, 6, 7, and 8 were higher in PAAD tissues than those in normal pancreatic tissue. The higher the expression levels of FZD2 and FZD7, the higher the clinical stage. The overall survival (OS) time was significantly different between low FZD3, 4, 5, 6, and 9 expression group and high expression group. Multivariable analysis showed that FZD3 and FZD6 were independent prognostic factors. The recurrence free survival (RFS) time was significantly different between low FZD4 and FZD8 expression group and high expression group. The RFS difference between low FZD6 expression group and high expression group had not reached statistical significance (p = 0.067), which might be due to the small sample size. However, multivariable analysis showed that FZD6 was the only independent factor for RFS. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that FZDs played a critical role in the Wnt signaling pathway, which was further confirmation that FZDs were transmembrane receptors of Wnt signaling pathway.
CONCLUSIONS: Our results strongly indicated a crucial role of the FZD family in PAAD. FZD3 and FZD6 could be potential prognostic and predictive markers, and FZD6 might also function as a potential therapeutic target in PAAD by blocking Wnt/β-catenin pathway.

Entities:  

Keywords:  Fzds; Pancreatic adenocarcinoma; Prognosis; TCGA

Mesh:

Year:  2021        PMID: 33618667      PMCID: PMC7901191          DOI: 10.1186/s12876-021-01643-6

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  42 in total

1.  Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Int J Oncol       Date:  2015-01-09       Impact factor: 5.650

2.  A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.

Authors:  Wei Xie; Yan Zhang; Yuan He; Kunchi Zhang; Guoqing Wan; Yanjuan Huang; Zhaoli Zhou; Gang Huang; Jin Wang
Journal:  Int J Biochem Cell Biol       Date:  2018-08-07       Impact factor: 5.085

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

4.  Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells.

Authors:  Rachel S Riley; Emily S Day
Journal:  Small       Date:  2017-05-22       Impact factor: 13.281

5.  WNT Stimulation Dissociates a Frizzled 4 Inactive-State Complex with Gα12/13.

Authors:  Elisa Arthofer; Belma Hot; Julian Petersen; Katerina Strakova; Stefan Jäger; Manuel Grundmann; Evi Kostenis; J Silvio Gutkind; Gunnar Schulte
Journal:  Mol Pharmacol       Date:  2016-07-25       Impact factor: 4.436

6.  Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.

Authors:  Neda Zarei; Mehdi Fazeli; Mozafar Mohammadi; Foroogh Nejatollahi
Journal:  Breast Cancer Res Treat       Date:  2018-02-06       Impact factor: 4.872

7.  Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer.

Authors:  Wenhu Liu; Jiangbei Yuan; Zhenzhong Liu; Jianwu Zhang; Jinxia Chang
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

8.  Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.

Authors:  Bingyao Liu; Gang Cao; Zhen Dong; Ting Guo
Journal:  Oncol Lett       Date:  2019-05-13       Impact factor: 2.967

9.  FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma.

Authors:  Li Huang; Er-Ling Luo; Jing Xie; Rui-Huan Gan; Lin-Can Ding; Bo-Hua Su; Yong Zhao; Li-Song Lin; Da-Li Zheng; You-Guang Lu
Journal:  Int J Biol Sci       Date:  2019-08-24       Impact factor: 6.580

10.  A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.

Authors:  S Lindsey Davis; Dana B Cardin; Safi Shahda; Heinz-Josef Lenz; Efrat Dotan; Bert H O'Neil; Ann M Kapoun; Robert J Stagg; Jordan Berlin; Wells A Messersmith; Steven J Cohen
Journal:  Invest New Drugs       Date:  2019-07-23       Impact factor: 3.850

View more
  4 in total

1.  Pan-Genomes Provide Insights into the Genetic Basis of Auricularia heimuer Domestication.

Authors:  Yuxiu Guo; Zhenhua Liu; Yongping Fu; Yu Li; Yueting Dai; Shijun Xiao
Journal:  J Fungi (Basel)       Date:  2022-05-29

2.  The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach.

Authors:  Mourad Assidi; Abdelbaset Buhmeida; Maryam H Al-Zahrani; Jaudah Al-Maghrabi; Mahmood Rasool; Muhammad I Naseer; Heba Alkhatabi; Abdulmajeed F Alrefaei; Ali Zari; Razan Elkhatib; Adel Abuzenadah; Peter N Pushparaj; Muhammad Abu-Elmagd
Journal:  Front Mol Biosci       Date:  2022-02-14

3.  GPCR genes as a predictor of glioma severity and clinical outcome.

Authors:  Eun-A Ko; Tong Zhou
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

4.  A Computational Framework to Identify Biomarkers for Glioma Recurrence and Potential Drugs Targeting Them.

Authors:  Shuzhi Ma; Zhen Guo; Bo Wang; Min Yang; Xuelian Yuan; Binbin Ji; Yan Wu; Size Chen
Journal:  Front Genet       Date:  2022-01-17       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.